LL-37 is effective against a wide range of pathogens, including Staphylococcus aureus , Escherichia coli , Pseudomonas aeruginosa , Helicobacter pylori , and various fungi and enveloped viruses
Together and individually, these peptides are not approved by WADA or the FDA, and remain experimental drugs, so they should not be on a retail shelf in the form of dietary supplements, especially not digital ones
Combination-Protocol Research Beyond the individual studies referenced above, several published research lines have specifically investigated BPC-157 and TB-500 in combination : Combined BPC-157 + TB-500 in musculoskeletal injury models searches across rodent rotator-cuff, Achilles tendon and ligament transection research
This ensures a safe and effective integration into wellness routines
Each compound is evaluated on its own terms by a provider